Instrument Inactif

Autres langues NPS Pharmaceuticals, Inc.

Actions

US62936P1030

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

12/02/15	Shire : Hausse du résultat du T4, le titre monte	RE
26/01/15	American Airlines : Les valeurs à suivre sur les marchés américains	RE

Autres langues

21/02/15	NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma
12/02/15	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval
06/02/15	NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis
26/01/15	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase
24/01/15	NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism
16/01/15	NPS Pharmaceuticals : NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc
14/01/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources
14/01/15	NPS Pharmaceuticals : NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc
13/01/15	NPS Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of NPS Pharmaceuticals, Inc.
13/01/15	NPS Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals, Inc. Stockholders
12/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil
12/01/15	NPS Pharmaceuticals : PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Pharmaceuticals, Inc. to Shire plc
12/01/15	NPS Pharmaceuticals : Buyout Of NPS Pharmaceuticals, Inc. - National Securities Law Firm Seeks Higher Price For Shareholders. Encourages Shareholders To Contact Law Firm For More Information
11/01/15	NPS Pharmaceuticals : PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech
05/01/15	NPS Pharmaceuticals : Pharma to Present at J.P. Morgan Healthcare Conference
17/12/14	AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg
04/12/14	NPS Pharmaceuticals : Pharma to Present at Oppenheimer Healthcare Conference
02/12/14	NPS Pharmaceuticals : European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism
25/11/14	NPS Pharmaceuticals : Pharma to Present at Deutsche Bank BioFEST Conference
24/11/14	NPS Pharmaceuticals : Teduglutide Granted Orphan Drug Designation in Japan
11/11/14	NPS Pharmaceuticals : Pharma to Present at Jefferies Global Healthcare Conference
10/11/14	NPS Pharmaceuticals : Pharma Reports Third-Quarter 2014 Financial Results
04/11/14	NPS Pharmaceuticals : Pharma Appoints Pierre Legault to Board of Directors
03/11/14	NPS Pharmaceuticals : Pharma to Report Third Quarter 2014 Financial Results
23/10/14	NPS Pharmaceuticals : PDUFA Action Date for Natpara® BLA Extended Three Months to January 24, 2015